Granuflo is a drug used during kidney dialysis; however, a large number of patients experienced heart problems after receiving the medication. With evidence suggesting that the drug manufacturer was aware of the dangers but failed to adequately warn physicians and consumers, individuals who have experienced serious medical issues after being exposed to Granuflo may be entitled to legal recourse. Reach out to our personal injury lawyers in Miami to get started.
The FDA issued a Class I recall on Granuflo after it was found that the product put patients at a heightened risk for cardiac arrest.
It’s been alleged that the manufacturer of the drug, Fresenius Medical Care, failed to adequately warn physicians that Granuflo contains more of an ingredient that the body converts to bicarbonate, which has been linked to heart problems.
According to an internal company memo, 941 patients treated at Fresenius’ dialysis centers experienced cardiac arrest in 2010. An analysis of the data showed that a patient’s risk of cardiac arrest was six times higher if they had high pre-dialysis bicarbonate levels. Even with this knowledge, Fresenius continued to market Granuflo and did not warn outside clinics that the drug seemed to contribute to a heightened risk of cardiac arrest. This became public knowledge in March 2012, after the FDA leaked Fresenius’ internal memo.





